Kieran P Fitzmaurice
Overview
Explore the profile of Kieran P Fitzmaurice including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thielking A, Fitzmaurice K, Sewpaul R, Chrysanthopoulou S, Dike L, Levy D, et al.
J Int AIDS Soc
. 2024 Jun;
27(6):e26315.
PMID: 38924347
Introduction: As access to effective antiretroviral therapy (ART) has improved globally, tobacco-related illnesses, including cardiovascular disease, cancer and chronic respiratory conditions, account for a growing proportion of deaths among people...
2.
Pei P, Fitzmaurice K, Le M, Panella C, Jones M, Pandya A, et al.
MDM Policy Pract
. 2023 Sep;
8(2):23814683231198873.
PMID: 37743931
Highlights: In conventional VOI analysis, it is assumed that the optimal decision will always be adopted even without a trial. This can potentially lead to an underestimation of the value...
3.
Siedner M, Alba C, Fitzmaurice K, Gilbert R, Scott J, Shebl F, et al.
J Infect Dis
. 2022 Jun;
226(11):1887-1896.
PMID: 35696544
Background: Despite the advent of safe and effective coronavirus disease 2019 vaccines, pervasive inequities in global vaccination persist. Methods: We projected health benefits and donor costs of delivering vaccines for...
4.
Reddy K, Fitzmaurice K, Scott J, Harling G, Lessells R, Panella C, et al.
Nat Commun
. 2021 Oct;
12(1):6238.
PMID: 34716349
Low- and middle-income countries are implementing COVID-19 vaccination strategies in light of varying vaccine efficacies and costs, supply shortages, and resource constraints. Here, we use a microsimulation model to evaluate...
5.
Reddy K, Fitzmaurice K, Scott J, Harling G, Lessells R, Panella C, et al.
medRxiv
. 2021 May;
PMID: 34013291
Low- and middle-income countries are implementing COVID-19 vaccination strategies in light of varying vaccine efficacies and costs, supply shortages, and resource constraints. Here, we use a microsimulation model to evaluate...
6.
Reddy K, Shebl F, Foote J, Harling G, Scott J, Panella C, et al.
Lancet Glob Health
. 2020 Nov;
9(2):e120-e129.
PMID: 33188729
Background: Health-care resource constraints in low-income and middle-income countries necessitate the identification of cost-effective public health interventions to address COVID-19. We aimed to develop a dynamic COVID-19 microsimulation model to...
7.
Reddy K, Shebl F, Foote J, Harling G, Scott J, Panella C, et al.
medRxiv
. 2020 Jul;
PMID: 32637979
Background: Healthcare resource constraints in low and middle-income countries necessitate selection of cost-effective public health interventions to address COVID-19. Methods: We developed a dynamic COVID-19 microsimulation model to evaluate clinical...